Key facts
- WriteWise’s last known valuation is $59.0M (Aug 2025).
- It has raised $17.0M across 1 recorded rounds; the latest was Early Stage VC ($5.0M) in Nov 2023.
- Notable investors include GreatPoint Ventures, Virtue (Austin), Altai Ventures, ManchesterStory.
- WriteWise has filed 1 Form D with the SEC, most recently Dec 2023 ($5.0M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for WriteWise
Funding rounds
1 roundsAbout WriteWise
Operator of a cost-contained health insurance platform intended for pharmacy-related costs. The company's platform connects insurance and reinsurance carriers with pharmacy benefit managers, managing general agents, benefits administrators, captive insurance companies, and other distribution partners, enabling employers to provide quality healthcare for their employees.
- Sector
- Financial Services
- HQ
- Boston, MA, United States
- Founded
- 2023
- Employees
- 7
- Website
- writewise.com/
- Ownership
- Privately Held (backing)
WriteWise doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WriteWise shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WriteWise in its N-PORT filings yet. We sweep new filings monthly.